Article Details
Retrieved on: 2024-06-28 19:48:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Wainwright maintained its Buy rating on Vigil Neuroscience Inc (NASDAQ: VIGL), underlining the company's potential in the biotechnology sector. The ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here